SCHEMBL25534178

SCHEMBL25534178

CC1(C)c2ccccc2-c2c(-c3cccc(-c4ccc(-c5cc(-c6ccc7ccccc7c6)nc(-c6cccc7ccccc67)n5)c5ccccc45)c3)cccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.40
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
CYP1A2 P05177 2/20 0.37
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
PSD A5PKW4 1/20 0.33
CHRNA1 P02708 1/20 0.33
CHRNG P07510 1/20 0.33
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
CHRND Q07001 1/20 0.33
ENPP3 O14638 1/20 0.33
ENPP1 P22413 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25534169 0.93 CYP1A1 (0.41) PIM1CYP1A1CYP1B1CYP1A2SLC6A2
SCHEMBL25534254 0.93 PIM1 (0.44) PIM1CYP1A1CYP1B1CYP1A2PSD
SCHEMBL25534070 0.93 PIM1 (0.44) PIM1CYP1A1CYP1B1CYP1A2PSD
SCHEMBL25534185 0.93 CHRNA1 (0.37) SLC6A2SLC6A4SLC6A3PSDCHRNA1
SCHEMBL25534180 0.92 CYP1A1 (0.41) PIM1CYP1A1CYP1B1CYP1A2SLC6A2
SCHEMBL25538025 0.92 CYP1A1 (0.41) PIM1CYP1A1CYP1B1CYP1A2SLC6A2
SCHEMBL25533603 0.92 PIM1 (0.41) PIM1CYP1A1CYP1B1CYP1A2SLC6A2
SCHEMBL25534176 0.92 CHRNA1 (0.35) CYP1A2SLC6A2SLC6A4SLC6A3PSD
SCHEMBL25533719 0.91 PIM1 (0.43) PIM1CYP1A1CYP1B1CYP1A2SLC6A2
SCHEMBL25533495 0.91 PIM1 (0.43) PIM1CYP1A1CYP1B1CYP1A2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM PIM1 1763/4885CYP1A1 888/4885CYP1B1 1273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.